Jove
Visualize
联系我们

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

238
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
238
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

221
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
221
Study Design in Statistics01:15

Study Design in Statistics

9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

876
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
876
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials.

JAMIA open·2026
Same author

ABO Incompatible Deceased Donor Liver Transplants in Infants (Age < 1 Year): A Single-Center Experience.

Pediatric transplantation·2026
Same author

Prevalence of Unmet Service Needs and Associated Person-Reported Outcomes in Long-Term Services and Supports in the United States.

Journal of the American Geriatrics Society·2026
Same author

Telehealth Use Among Older Adults Receiving Home- and Community-Based Services: Cross-Sectional Analysis Using the National Core Indicators-Aging and Disabilities Survey.

JMIR human factors·2026
Same author

Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

When to assess responses to treatments in adaptive interventions? An experimental analysis of assessment timing in a smoking cessation treatment in the context of lung cancer screening.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same journal

Statistical analysis of disease onset during lifespan with left truncation.

Biometrics·2026
Same journal

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 13, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

在随机对照试验中共同建模多个终点,以有效估计随机对照试验中的治疗效果.

Jack M Wolf1,2, Joseph S Koopmeiners2, David M Vock2

  • 1Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA 19104, United States.

Biometrics
|January 8, 2026
PubMed
概括
此摘要是机器生成的。

本研究引入了一种新方法,通过使用初级和二级终点来提高临床试验结果的准确性. 这种方法增强了对研究结果的信心,特别是在烟草监管科学研究方面.

关键词:
效率 效率 效率 效率 效率 效率 效率 效率联合模型 联合模型随机对照试验是随机对照试验.二次终点是二次终点.结构方程模型的结构方程模型.

更多相关视频

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.3K

相关实验视频

Last Updated: Jan 13, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.3K

科学领域:

  • 生物统计学 生物统计学
  • 临床试验 临床试验
  • 烟草监管科学 烟草监管科学

背景情况:

  • 随机对照试验 (RCT) 对于评估干预疗效至关重要.
  • 在RCT中一个常见的挑战是科学相关的初级终点和更强大,更不相关的初级终点之间的权衡.
  • 小组分析往往没有足够的力量,限制了它们的实用性.

研究的目的:

  • 通过结合来自二次终点的信息来开发对治疗对主要终点的影响的改进估计器.
  • 提高临床试验分析的统计能力和稳定性.
  • 提供一种利用多个终点的方法,以提高对试验结果的信心.

主要方法:

  • 开发了一种基于初级和二级疗效终点的联合模型的治疗效果新型估计器.
  • 采用模型的平均值,以确保对潜在的模型错误规范的稳定性.
  • 应用该方法来估计极低尼古丁含量的香烟对吸烟禁欲的影响.

主要成果:

  • 与标准方法相比,当联合模型被正确指定时,拟议的估计器显示了效率的提高.
  • 这种方法被证明是强大的模型错误规范通过模型平均.
  • 在一个特定的应用中,该方法在评估禁烟时,将标准误差降低了27%.

结论:

  • 开发的联合建模方法有效地利用二次终点来改善对初级终点治疗效应的估计.
  • 这种方法为分析临床试验数据提供了一个统计学上稳健和更强大的替代方案,特别是在烟草监管科学等领域.
  • 这些发现表明,这是一种有价值的工具,可以提高通过多种疗效测量来解释和提高临床试验证据的可靠性.